サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1206308

中南米のインフルエンザワクチン市場の2028年までの予測-地域分析- ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別

South & Central America Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group
出版日: | 発行: The Insight Partners | ページ情報: 英文 132 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
中南米のインフルエンザワクチン市場の2028年までの予測-地域分析- ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ別
出版日: 2023年01月10日
発行: The Insight Partners
ページ情報: 英文 132 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米のインフルエンザワクチン市場は、2022年の4億9,754万米ドルから2028年には7億3,635万米ドルに成長すると予測され、2022年から2028年までのCAGRは6.8%と推定されています。

インフルエンザワクチン接種を促進するための政府支援の増加

さまざまな州や国の統治機関は、複数の活動やプログラムを通じて、ワクチン接種の促進を支援しています。2022年までに、NIPを通じて政府資金によるインフルエンザワクチンの接種対象となるすべてのリスクグループをカバーするのに十分なワクチンが確保されました。

以下、インフルエンザワクチン接種に対する政府の支援を裏付ける事例をいくつか紹介します：2021年10月、インフルエンザの季節が近づく中、州政府はニューファンドランド人とラブラドール人全員にインフルエンザの予防接種を受けるよう呼びかけていました。2021年10月25日から、地域保健局（RHA）は無料のインフルエンザ予防接種クリニックの開催を開始しました。また、人々はかかりつけの医師や地元の薬局を通じてワクチンを接種することができます。このように、インフルエンザワクチン接種を促進するための政府支援の増加が、中南米のインフルエンザワクチン市場を牽引しています。

市場概要

中南米のインフルエンザワクチン市場は、ブラジル、アルゼンチン、その他中南米に区分されます。同地域のインフルエンザワクチン市場は、予測期間中に成長機会が訪れると期待されています。同地域のインフルエンザワクチン市場は、同地域におけるインフルエンザ患者の増加、同地域における各種研究活動の活発化、健康意識の高まり、同地域の国々による医療費の増加などの要因によって成長すると予想されます。

中南米インフルエンザワクチン市場の収益と2028年までの予測（百万米ドル）

中南米のインフルエンザワクチン市場のセグメンテーション

中南米のインフルエンザワクチン市場は、ワクチンタイプ、ウイルスタイプ、技術、投与経路、ターゲットグループ、国に基づいてセグメント化されています。

ワクチンタイプに基づき、中南米のインフルエンザワクチン市場は4価ワクチンと3価ワクチンに二分化されます。4価ワクチンセグメントは、2022年に市場でより大きなシェアを登録しました。

ウイルスタイプに基づき、中南米のインフルエンザワクチン市場はインフルエンザウイルスA型とインフルエンザウイルスB型に二分され、2022年にはインフルエンザウイルスA型セグメントがより大きなシェアを占めています。

技術に基づき、中南米のインフルエンザワクチン市場は卵ベースと細胞ベースに分けられます。2022年の市場では、卵ベースのセグメントがより大きなシェアを占めています。

投与経路に基づき、中南米のインフルエンザワクチン市場は、注射と鼻腔スプレーに分けられます。2022年の市場では、注射剤がより大きなシェアを占めています。

ターゲットグループに基づき、中南米インフルエンザワクチン市場は、乳幼児、小児、成人、高齢者に区分けされます。2022年の市場では、乳幼児セグメントが最も大きなシェアを占めています。

国別に見ると、中南米のインフルエンザワクチン市場は、ブラジル、アルゼンチン、その他中南米に区分されます。2022年はブラジルが市場を独占しました。

AstraZeneca、GlaxoSmithKline plc.、三菱化学グループ、MYLAN N.V.、Sanofi、SEQIRUS、Serum Institute of India Pvt. Ltdは、南＆中米のインフルエンザワクチン市場で活動している主要企業です。

目次

第1章 イントロダクション

  • 調査範囲
  • 洞察パートナーズの調査報告書ガイダンス
  • 市場セグメンテーション
    • 中南米のインフルエンザワクチン市場：ワクチンタイプ別
    • 中南米のインフルエンザワクチン市場：ウイルスタイプ別
    • 中南米のインフルエンザワクチン市場-技術別
    • 中南米のインフルエンザワクチン市場：投与経路別
    • 中南米のインフルエンザワクチン市場：ターゲットグループ別
    • 中南米のインフルエンザワクチン市場-国別

第2章 南米・中米のインフルエンザワクチン市場- 重要なポイント

第3章 調査手法

  • 調査対象
  • 2次調査
  • 1次調査

第4章 中南米のインフルエンザワクチン市場- 市場情勢

  • PEST分析
    • 中南米のPEST分析
  • 専門家別オピニオン

第5章 中南米のインフルエンザワクチン市場- 主な市場力学

  • 市場促進要因
    • インフルエンザワクチン接種を促進するための政府支援の増加
    • トップ企業と政府別投資の増加
  • 市場抑制要因
    • ワクチン開発コストの高さ
  • 市場機会
    • 新興国
  • 今後の動向
    • インフルエンザワクチンの強力な候補パイプライン
  • インパクトのある分析

第6章 インフルエンザワクチン市場-中南米の分析

  • 中南米のインフルエンザワクチン市場：国別予測・分析
  • 中南米のインフルエンザワクチン市場の収益と予測・分析
    • 中南米：インフルエンザワクチン市場、2019年～2028年

第7章 中南米のインフルエンザワクチン市場の分析と2028年までの予測- ワクチンタイプ別

  • 中南米のインフルエンザワクチン市場：ワクチンタイプ別2022年・2028年（%）
  • 4価ワクチン
  • 3価ワクチン

第8章 中南米インフルエンザワクチン市場の分析と2028年までの予測：ウイルスタイプ別

  • 中南米のインフルエンザワクチン市場：ウイルスタイプ別2022年・2028年（%）
  • インフルエンザウイルスA型
  • インフルエンザウイルスB型

第9章 中南米インフルエンザワクチン市場の分析と2028年までの予測：技術別

  • 中南米のインフルエンザワクチン市場：技術別2022年・2028年（%）
  • 卵子ベース
  • セルベース

第10章 中南米のインフルエンザワクチン市場の分析と2028年までの予測：投与経路別

  • 中南米のインフルエンザワクチン市場：投与経路別2022年・2028年（%）
  • 注射剤
  • 鼻腔スプレー

第11章 中南米のインフルエンザワクチン市場の分析と2028年までの予測：ターゲットグループ別

  • 中南米のインフルエンザワクチン市場：ターゲットグループ別2022年・2028年（%）
  • 乳幼児
  • 小児
  • 成人
  • 高齢者（Elderly People

第12章 中南米のインフルエンザワクチン市場の分析と2028年までの予測- 国別分析

    • 中南米地域
      • ブラジル
      • アルゼンチン
      • その他中南米地域

第13章 中南米のインフルエンザワクチン市場-業界情勢

  • インフルエンザワクチン市場の成長戦略、2021年～2028年
  • 無機的な成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • SEQIRUS
  • Sanofi
  • GlaxoSmithKline plc.
  • Mitsubishi Chemical Group Corporation
  • Serum Institute of India Pvt. Ltd
  • MYLAN N.V.
  • AstraZeneca

第15章 付録

  • The Insight Partners について
  • 用語集
図表

List Of Tables

  • Table 1. Below are a few instances of companies and their pipeline products:
  • Table 2. South & Central America Influenza Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 4. South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 5. South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 6. South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Brazil: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Brazil: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Brazil: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Brazil: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 11. Brazil Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 12. Argentina: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Argentina: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Argentina: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Argentina: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 16. Argentina Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 17. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Rest of South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 19. Rest of South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 20. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 21. Rest of South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 22. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
  • Table 23. Recent Organic Growth Strategies in the Influenza Vaccine Market
  • Table 24. Glossary of Terms, Influenza Vaccines Market

List Of Figures

  • Figure 1. South & Central America Influenza Vaccines Market Segmentation
  • Figure 2. South & Central America Influenza Vaccines Market Segmentation, by Country
  • Figure 3. South & Central America Influenza Vaccines Market Overview
  • Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in South & Central America Influenza Vaccines Market
  • Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. South and Central America: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. South & Central America Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
  • Figure 9. South & Central America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
  • Figure 10. Quadrivalent Vaccines: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Trivalent Vaccines: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. South & Central America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
  • Figure 13. Influenza Virus Type A : Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. South & Central America Influenza Vaccines Market, by Technology 2022 & 2028 (%)
  • Figure 16. Egg-based: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. Cell-Based: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. South & Central America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
  • Figure 19. Injection: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. Nasal Spray: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 21. South & Central America Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
  • Figure 22. Infants : South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. Children: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 24. Adults: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Elderly People: South & Central America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. South and Central America: Influenza Vaccine Market, by Key Country - Revenue (2022) (USD Million)
  • Figure 27. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  • Figure 28. Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 29. Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 30. Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 31. Growth Strategies in the Influenza Vaccine Market, 2021-2028
目次
Product Code: BMIRE00026974

The South & Central America influenza vaccines market is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2022 to 2028.

Increase in Government Support to Promote Influenza Vaccination

The governing bodies of various states and countries are supporting the promotion of vaccination through multiple activities and programs. By 2022, enough vaccines have been secured to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Below are a few more instances supporting the government support for influenza vaccination: In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination is driving the South & Central America influenza vaccines market.

Market Overview

The South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market for influenza vaccines in the region is expected to experience growth opportunities during the forecast period. The influenza vaccines market in SAM is expected to grow owing to factors such as an increase in cases of influenza in the region, surge in various research activities in the region, rise in health awareness, and an increase in healthcare expenditure by the countries of the region.

South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Influenza Vaccines Market Segmentation

The South & Central America influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.

Based on vaccine type, the South & Central America influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.

Based on virus type, the South & Central America influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.

Based on technology, the South & Central America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.

Based on route of administration, the South & Central America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.

Based on target group, the South & Central America influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.

Based on country, the South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market in 2022.

AstraZeneca; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the South & Central America influenza vaccines market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America influenza vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Influenza Vaccines Market - By Vaccine Type
    • 1.3.2 South & Central America Influenza Vaccines Market - By Virus Type
    • 1.3.3 South & Central America Influenza Vaccines Market - By Technology
    • 1.3.4 South & Central America Influenza Vaccines Market - By Route of Administration
    • 1.3.5 South & Central America Influenza Vaccines Market - By Target Group
    • 1.3.6 South & Central America Influenza Vaccines Market - By Country

2. South & Central America Influenza Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Influenza Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South and Central America PEST Analysis
  • 4.3 Experts Opinion

5. South & Central America Influenza Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Government Support to Promote Influenza Vaccination
    • 5.1.2 Increasing Investment by Top Market Players and Governments
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Vaccine Development
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Strong Pipeline Candidates for Influenza Vaccines
  • 5.5 Impact Analysis

6. Influenza Vaccine Market - South & Central America Analysis

  • 6.1 South & Central America Influenza Vaccines Market, By Country - Forecasts And Analysis
  • 6.2 South & Central America Influenza Vaccines Market Revenue Forecasts And Analysis
    • 6.2.1 South & Central America : Influenza Vaccines Market, 2019-2028 (US$ Million)

7. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

  • 7.1 Overview
  • 7.2 South & Central America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
    • 7.2.1 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
  • 7.3 Quadrivalent Vaccines
    • 7.3.1 Overview
    • 7.3.2 Quadrivalent Vaccines : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Trivalent Vaccines
    • 7.4.1 Overview
    • 7.4.2 Trivalent Vaccines : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

  • 8.1 Overview
  • 8.2 South & Central America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
    • 8.2.1 South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
  • 8.3 Influenza Virus Type A
    • 8.3.1 Overview
    • 8.3.2 Influenza Virus Type A : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Influenza Virus Type B
    • 8.4.1 Overview
    • 8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

  • 9.1 Overview
  • 9.2 South & Central America Influenza Vaccines Market, By Technology 2022 & 2028 (%)
    • 9.2.1 South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
  • 9.3 Egg-based
    • 9.3.1 Overview
    • 9.3.2 Egg-based : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Cell-based
    • 9.4.1 Overview
    • 9.4.2 Cell-Based : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

  • 10.1 Overview
  • 10.2 South & Central America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
  • 10.3 Injection
    • 10.3.1 Overview
    • 10.3.2 Injection : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Nasal Spray
    • 10.4.1 Overview
    • 10.4.2 Nasal Spray: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

  • 11.1 Overview
  • 11.2 South & Central America Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
    • 11.2.1 South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 11.3 Infants
    • 11.3.1 Overview
    • 11.3.2 Infants : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Children
    • 11.4.1 Overview
    • 11.4.2 Children: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Adults
    • 11.5.1 Overview
    • 11.5.2 Adults : South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Elderly People
    • 11.6.1 Overview
    • 11.6.2 Elderly People: South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. South & Central America Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis

  • 12.1 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
    • 12.1.1 Overview
    • 12.1.3 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
      • 12.1.3.1 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.3.1.1 Overview
        • 12.1.3.1.2 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.3.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.3.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.3.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.1.3.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.1.3.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.3.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.3.2.1 Overview
        • 12.1.3.2.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.3.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.3.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.3.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.1.3.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.1.3.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.3.3 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.3.3.1 Overview
        • 12.1.3.3.2 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.1.3.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.1.3.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.1.3.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.1.3.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.1.3.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)

13. South & Central America Influenza Vaccine Market -Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 SEQIRUS
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sanofi
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GlaxoSmithKline plc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Mitsubishi Chemical Group Corporation
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Serum Institute of India Pvt. Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 MYLAN N.V.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 AstraZeneca
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms